Feb 10, 2026
BeyondSpring to Participate at the 12th Annual Immuno-Oncology 360◦ Conference
Dec 12, 2025
BeyondSpring Announces ESMO Asia Presentation on Plinabulin + Docetaxel Improving…
Dec 11, 2025
BeyondSpring Announces New Analyses of DUBLIN-3 Phase 3 Study Showing…
Jun 27, 2025
Med (Cell Press) 2025
Sep 19, 2024
Lancet Respiratory Medicine 2024
Sep 14, 2023
JNCCN 2023
Nov 16, 2025
PP01.45: Phase 3 Study of Plinabulin/Docetaxel vs. Docetaxel in 2L/3L…
Oct 23, 2025
Phase 2 study of pembrolizumab (Pemb) plus plinabulin (Plin) and…
Sep 10, 2025
Immune Activation with Plinabulin Enhances Anti-tumor Response Combining Radiation with…
Jun 11, 2020
June 11, 2020 PROTECTIVE-2 (Study 106) Phase 3 Interim Analysis…
Jun 09, 2020
June 11, 2020 – Plinabulin in Combination with Neulasta Improves…
Jun 03, 2020
June 03, 2020 – DSMB Reviewed Over 500 Patients’ Data…
Jun 02, 2020
May 13, 2020 NEW YORK, May 13, 2020 (GLOBE NEWSWIRE)…
May 16, 2020
04.15.2018 American Association for Cancer Research (AACR) Annual Meeting (2018)…
06.04.2018 American Society of Clinical Oncology (ASCO) Annual Meeting (2018)…
09.24.2018 International Association for the Study of Lung Cancer (IASLC)…
10.15.2018 Society for Leukocyte Biology and International Endotoxin and Innate…
May 13, 2020
June 02, 2020 NEW YORK, June 02, 2020 (GLOBE NEWSWIRE)…
Email us at
Call us at
Office location